Screener
Viemed Healthcare, Inc. VMD EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Viemed Healthcare, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 5:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001729149-26-000029
| Line item | Note | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|---|
| Net income attributable to noncontrolling interest | 131 | 85 | |
| Net income attributable to Viemed Healthcare, Inc. | $2,582 | $2,625 | |
| Net income per share | |||
| Basic | 11 | $0.07 | $0.07 |
| Diluted | 11 | $0.06 | $0.06 |
| Weighted average number of common shares outstanding: | |||
| Basic | 11 | 38,428,588 | 39,426,753 |
| Diluted | 11 | 40,491,298 | 41,627,876 |
Item 1. Financial Statements
FAQ
- What is Viemed Healthcare, Inc.'s EPS (diluted)?
- Viemed Healthcare, Inc. (VMD) reported EPS (diluted) of $0.06 in Q1 2026.
- How has Viemed Healthcare, Inc.'s EPS (diluted) changed year-over-year?
- Viemed Healthcare, Inc.'s EPS (diluted) decreased by 0.0% year-over-year, from $0.06 to $0.06.
- What is the long-term trend for Viemed Healthcare, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Viemed Healthcare, Inc.'s EPS (diluted) has grown at a 13.9% compound annual growth rate (CAGR), from $0.22 to $0.37.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Viemed Healthcare, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude